Chronic obstructive pulmonary disease as a risk factor for lung cancer

per Takiguchi, Yuichi, Sekine, Ikuo, Iwasawa, Shunichiro, Kurimoto, Ryota, Tatsumi, Koichiro
Publicat 2014

ALK Rearrangement Adenocarcinoma with Histological Transformation to Squamous Cell Carcinoma Resistant to Alectinib and Ceritinib

per Kaiho, Taisuke, Nakajima, Takahiro, Iwasawa, Shunichiro, Yonemori, Yoko, Yoshino, Ichiro
Publicat a Onco Targets Ther (2020)

Crizotinib-Induced Abnormal Signal Processing in the Retina

per Ishii, Toshiyuki, Iwasawa, Shunichiro, Kurimoto, Ryota, Maeda, Akemi, Takiguchi, Yuichi, Kaneda, Makoto
Publicat a PLoS One (2015)

Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinoma

per Kurimoto, Ryota, Ebata, Takahiro, Iwasawa, Shunichiro, Ishiwata, Tsukasa, Tada, Yuji, Tatsumi, Koichiro, Takiguchi, Yuichi
Publicat a Oncol Lett (2017)

Potential Activity of Amrubicin as a Salvage Therapy for Merkel Cell Carcinoma

per Sakaida, Emiko, Ebata, Takahiro, Iwasawa, Shunichiro, Kurimoto, Ryota, Yonemori, Sachiko, Ota, Satoshi, Nakatani, Yukio, Sekine, Ikuo, Takiguchi, Yuichi
Publicat a Intern Med (2017)

Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation

per KURIMOTO, RYOTA, IWASAWA, SHUNICHIRO, EBATA, TAKAHIRO, ISHIWATA, TSUKASA, SEKINE, IKUO, TADA, YUJI, TATSUMI, KOICHIRO, KOIDE, SHUHEI, IWAMA, ATSUSHI, TAKIGUCHI, YUICHI
Publicat a Int J Oncol (2016)

Safety of a short hydration method for cisplatin administration in comparison with a conventional method—a retrospective study

per Sakaida, Emiko, Iwasawa, Shunichiro, Kurimoto, Ryota, Ebata, Takahiro, Imai, Chiaki, Oku, Tomoko, Sekine, Ikuo, Tada, Yuji, Tatsumi, Koichiro, Takiguchi, Yuichi
Publicat a Jpn J Clin Oncol (2016)

Nivolumab-induced Acute Fibrinous and Organizing Pneumonia (AFOP)

per Ishiwata, Tsukasa, Ebata, Takahiro, Iwasawa, Shunichiro, Matsushima, Jun, Ota, Satoshi, Nakatani, Yukio, Tsushima, Kenji, Tada, Yuji, Tatsumi, Koichiro, Takiguchi, Yuichi
Publicat a Intern Med (2017)

A phase II study of atezolizumab for pretreated advanced/recurrent non-small cell lung cancer with idiopathic interstitial pneumonias: rationale and design for the TORG1936/AMBITIO...

per Ikeda, Satoshi, Kato, Terufumi, Kenmotsu, Hirotsugu, Ogura, Takashi, Iwasawa, Shunichiro, Iwasawa, Tae, Kasajima, Rika, Miyagi, Yohei, Misumi, Toshihiro, Yamanaka, Takeharu, Okamoto, Hiroaki
Publicat a Ther Adv Med Oncol (2020)

Clinical characteristics and risk factors of drug‐induced lung injury by ALK tyrosine kinase inhibitors: A single center retrospective analysis

per Koshikawa, Ken, Terada, Jiro, Abe, Mitsuhiro, Iwasawa, Shunichiro, Sakayori, Masashi, Yoshioka, Keiichiro, Hirasawa, Yasutaka, Kasai, Hajime, Kawasaki, Yohei, Tsushima, Kenji, Tatsumi, Koichiro
Publicat a Thorac Cancer (2020)

Spondylodiscitis and spinal epidural abscess related to long‐term placement of an airway stent for malignant central airway obstruction

per Shikano, Kohei, Ishii, Daisuke, Umimura, Tomotaka, Rakuman, Shintaro, Maki, Satoshi, Kasai, Hajime, Orita, Sumihisa, Iwasawa, Shunichiro, Sugiura, Toshihiko, Ohtori, Seiji, Tatsumi, Koichiro
Publicat a Thorac Cancer (2020)

Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015

per Kozuki, Toshiyuki, Nogami, Naoyuki, Kitajima, Hiromoto, Iwasawa, Shunichiro, Sakaida, Emiko, Takiguchi, Yuichi, Ikeda, Satoshi, Yoshida, Masahiro, Kato, Terufumi, Miyamoto, Shingo, Sakamaki, Kentaro, Shinkai, Tetsu, Watanabe, Koshiro
Publicat a BMC Cancer (2016)

Nocturnal Hypoxemia and High Circulating TNF-α Levels in Chronic Thromboembolic Pulmonary Hypertension

per Naito, Akira, Sakao, Seiichiro, Terada, Jiro, Iwasawa, Shunichiro, Jujo Sanada, Takayuki, Suda, Rika, Kasai, Hajime, Sekine, Ayumi, Nishimura, Rintaro, Sugiura, Toshihiko, Shigeta, Ayako, Tanabe, Nobuhiro, Tatsumi, Koichiro
Publicat a Intern Med (2020)

Characterization of pulmonary intimal sarcoma cells isolated from a surgical specimen: In vitro and in vivo study

per Sanada, Takayuki Jujo, Sakao, Seiichiro, Naito, Akira, Ishibashi-Ueda, Hatsue, Suga, Masaki, Shoji, Hiroki, Miwa, Hideki, Suda, Rika, Iwasawa, Shunichiro, Tada, Yuji, Ishida, Keiichi, Tanabe, Nobuhiro, Tatsumi, Koichiro
Publicat a PLoS One (2019)

A Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial Pneumonitis

per Ikeda, Satoshi, Kato, Terufumi, Kenmotsu, Hirotsugu, Ogura, Takashi, Iwasawa, Shunichiro, Sato, Yuki, Harada, Toshiyuki, Kubota, Kaoru, Tokito, Takaaki, Okamoto, Isamu, Furuya, Naoki, Yokoyama, Toshihide, Hosokawa, Shinobu, Iwasawa, Tae, Yamanaka, Takeharu, Okamoto, Hiroaki
Publicat a J Thorac Oncol (2020)

Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease

per Ikari, Jun, Nelson, Amy J., Obaid, Jannah, Giron-Martinez, Alvaro, Ikari, Kumiko, Makino, Fumihiko, Iwasawa, Shunichiro, Gunji, Yoko, Farid, Maha, Wang, Xingqi, Basma, Hesham, Demeo, Dawn, Feghali-Bostwick, Carol, Holz, Olaf, Rabe, Klaus, Liu, Xiangde, Rennard, Stephen I.
Publicat a PLoS One (2017)

Prognostic Factors and Efficacy of First‐Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study

per Ko, Ryo, Shukuya, Takehito, Okuma, Yusuke, Tateishi, Kazunari, Imai, Hisao, Iwasawa, Shunichiro, Miyauchi, Eisaku, Fujiwara, Akiko, Sugiyama, Tomohide, Azuma, Keisuke, Muraki, Keiko, Yamasaki, Masahiro, Tanaka, Hisashi, Takashima, Yuta, Soda, Sayo, Ishimoto, Osamu, Koyama, Nobuyuki, Morita, Satoshi, Kobayashi, Kunihiko, Nukiwa, Toshihiro, Takahashi, Kazuhisa
Publicat a Oncologist (2018)

Reprogramming of COPD lung fibroblasts through formation of induced pluripotent stem cells

per Basma, Hesham, Gunji, Yoko, Iwasawa, Shunichiro, Nelson, Amy, Farid, Maha, Ikari, Jun, Liu, Xiangde, Wang, Xingqi, Michalski, Joel, Smith, Lynette, Iqbal, Javeed, Behery, Radwa El, West, William, Yelamanchili, Sowmya, Rennard, Deborah, Holz, Olaf, Mueller, Kai-Christian, Magnussen, Helgo, Rabe, Klaus, Castaldi, Peter J, Rennard, Stephen I.
Publicat 2014

Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study

per Fukuhara, Tatsuro, Saito, Haruhiro, Furuya, Naoki, Watanabe, Kana, Sugawara, Shunichi, Iwasawa, Shunichiro, Tsunezuka, Yoshio, Yamaguchi, Ou, Okada, Prof Morihito, Yoshimori, Kozo, Nakachi, Ichiro, Gemma, Prof Akihiko, Azuma, Koichi, Kurimoto, Futoshi, Tsubata, Yukari, Fujita, Yuka, Nagashima, Hiromi, Asai, Gyo, Watanabe, Satoshi, Miyazaki, Masaki, Hagiwara, Prof Koichi, Nukiwa, Prof Toshihiro, Morita, Prof Satoshi, Kobayashi, Prof Kunihiko, Maemondo, Prof Makoto
Publicat a EBioMedicine (2020)